One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Safety and Tolerability of Inclisiran for Treatment of Hypercholesterolemia in 7 Clinical Trials
R. Scott Wright, MD,a Wolfgang Koenig, MD, b,c Ulf Landmesser, MD, d Lawrence A. Leiter, MD, e Frederick J. Raal, MD, f Gregory G. Schwartz, MD,g Anastasia Lesogor, MD, h Pierre Maheux, MD, h Christian Stratz, MD, h Xiao Zang, PHD, i Kausik K. Ray, MD
doi : 10.1016/j.jacc.2023.10.007
Volume 82, Issue 24, 12 December 2023, Pages 2251-2261
Inclisiran: Where Are We on Safety, Efficacy, and Clinical Effectiveness of siRNA Therapies for Prevention?∗
Christie M. Ballantyne, MD,a Abdul Mannan Khan Minhas, MD, a Carl E. Orringer, MD
Lipoprotein(a) and Risks of Peripheral Artery Disease, Abdominal Aortic Aneurysm, and Major Adverse Limb Events
Peter E. Thomas, MD,a,b,c Signe Vedel-Krogh, MD, PH D, a,b,c Sune F. Nielsen, PH D, a,b B?rge G. Nordestgaard, MD, DMS C,a,b,c Pia R. Kamstrup, MD, PH D
doi : 10.1016/j.jacc.2023.10.009
Volume 82, Issue 24, 12 December 2023, Pages 2265-2276
Lipoprotein(a), Peripheral Artery Disease, and Abdominal Aortic Aneurysm: The Next Frontier or Another Risk Enhancer?∗
Joshua A. Beckman, MD, MS, a Alexander E. Sullivan, MD
doi : 10.1016/j.jacc.2023.10.015
Volume 82, Issue 24, 12 December 2023, Pages 2277-2279
Association of Lipoprotein(a) Levels With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis
Omar Chehab, MD, MS, a Ashkan Abdollahi, MD,a Seamus P. Whelton, MD, MPH,a Colin O. Wu, PHD, b Bharath Ambale-Venkatesh, PH D, c Wendy S. Post, MD, MS, a David A. Bluemke, MD,d Michael Y. Tsai, PHD, e Jo?o A.C. Lima, MD, MBA
doi : 10.1016/j.jacc.2023.10.016
Volume 82, Issue 24, 12 December 2023, Pages 2280-2291
Lipoprotein(a): More Than Just a Biomarker of Myocardial Fibrosis∗
Gilles Lambert, PH D, a Kévin Chemello, PHD, a Antonio Gallo, MD, P HD
doi : 10.1016/j.jacc.2023.10.019
Volume 82, Issue 24, 12 December 2023, Pages 2292-2295
Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease
R. Mark Payne, MD,a Kristin M. Burns, MD,b Andrew C. Glatz, MD, MSCE, c Christoph Male, MD, MS C,d Andrea Donti, MD, e Leonardo R. Brand?o, MD, MS C,f,g,h Gunter Balling, MD,i Christina J. VanderPluym, MD,j Frances Bu’Lock, MD,k Lazaros K. Kochilas, MD, MSCR, l Brigitte Stiller, MD, m James F. Cnota II, MD, MS, n Otto Rahkonen, MD, o Asra Khan, MD,p Rachele Adorisio, MD,q Serban Stoica, MD,r Lindsay May, MD, s Jane C. Burns, MD, t Jose Francisco K. Saraiva, MD, PHD, u Kimberly E. McHugh, MD, MSCR, v John S. Kim, MD,w Agustin Rubio, MD,x Nadia G. Ch?a-Vazquez, MD, y Marcie R. Meador, PHD, BSN, RN,p Joshua L. Dyme, MD, z Alison M. Reedy, P HD, z Toni Ajavon-Hartmann, PH D, z Praneeth Jarugula, PHARMD, z Lauren E. Carlson-Taneja, MPH,z Donna Mills, RN, z Olivia Wheaton, BS, aa Paul Monagle, MBBS, MS C, MD
doi : 10.1016/j.jacc.2023.10.010
Volume 82, Issue 24, 12 December 2023, Pages 2296-2309
Apixaban for Children With Heart Disease∗
Craig A. Mullen, MD, P HD
doi : 10.1016/j.jacc.2023.10.011
Volume 82, Issue 24, 12 December 2023, Pages 2310-2311
Disparities in Diagnosis, Treatment, and Outcomes of Peripheral Artery Disease: JACC Scientific Statement
Mary M. McDermott, MD, a Karen J. Ho, MD,a Olamide Alabi, MD, MS, b Michael H. Criqui, MD, MPH,c Philip Goodney, MD, MS, d Naomi Hamburg, MD, MS,e Demetria M. McNeal, P HD, MBA, f Amy Pollak, MD,g Kim G. Smolderen, PH D, MSC ,h Marc Bonaca, MD, MPH
doi : 10.1016/j.jacc.2023.09.830
Volume 82, Issue 24, 12 December 2023, Pages 2312-2328
Research Priorities in Critical Care Cardiology: JACC Expert Panel
P. Elliott Miller, MD, MHS,a Kurt Huber, MD,b Erin A. Bohula, MD, DPHIL ,c Konstantin A. Krychtiuk, MD, PHD, d,e Janine P?ss, MD,f Robert O. Roswell, MD,g Guido Tavazzi, MD, PHD, h Michael A. Solomon, MD, MBA, i Steen D. Kristensen, MD, DMS C,j David A. Morrow, MD, MPH, c on behalf of the ACC’s Critical Care Cardiology Member Section and the ESC Association for Acute CardioVascular Care
doi : 10.1016/j.jacc.2023.09.828
Volume 82, Issue 24, 12 December 2023, Pages 2329-2337
Role of Advanced Practice Providers in the Cardiac Intensive Care Unit Team
Carolina D. Tennyson, DNP, ACNP-BC,a Margaret T. Bowers, DNP, FNP-BC, a Allison W. Dimsdale, DNP, NP-C, b Sharon M. Dickinson, PA-C, c R. Monica Sanford, DNP, ACNP-BC, d Jordan D. McKenzie-Solis, AGACNP-BC, e Hannah D. Schimmer, MSN, AGACNP-BC, f Carlos L. Alviar, MD,f Shashank S. Sinha, MD, MS C, g Jason N. Katz, MD, MHS
doi : 10.1016/j.jacc.2023.08.061
Volume 82, Issue 24, 12 December 2023, Pages 2338-2342
Potential Expanded Applications of Minimally Invasive Cardiac Myectomy
*Ramdas G. Pai, MD
doi : 10.1016/j.jacc.2023.09.829
Volume 82, Issue 24, 12 December 2023, Page e235
Reply: Potential Expanded Applications of Minimally Invasive Cardiac Myectomy
Jing Fang, MD, PhD a,b,c Yani Liu, MD, PhDa Song Wan, MD, PhDd *Xiang Wei, MD, PhD
doi : 10.1016/j.jacc.2023.10.012
Volume 82, Issue 24, 12 December 2023, Page e237
